Getting your yearly flu vaccine is essential to prevent illness during cold and flu season. But if you’re not a fan of ...
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...
On September 20, 2024, the U.S. Food & Drug Administration (FDA) announced they had approved an at-home nasal spray influenza ...
People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
FluMist (influenza vaccine live, intranasal) is a vaccine used to help prevent flu. FluMist can cause side effects that range from mild to serious. Examples include runny nose, congestion ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...